
|Articles|June 1, 2010
Cross linking revolution
Experience the revolution in cross linking at booth 15 B 50 where bon Optic will be showing the new Ricrolin TE from the company Sooft.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
2
FLORetina 2025: Port delivery system shows reliable 6-month durability and sustained efficacy in neovascular AMD for up to 7 years
3
FLORetina 2025: Fibrosis, a limiting factor in visual acuity outcomes in neovascular AMD
4
FLORetina 2025: Weight and PMA drive foveal maturation in preterm infants
5













































